Concord Biotech Limited (CONCORDBIO.BO)
INR 2153.4
(-1.05%)
INR 2153.4
(-1.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.11 Billion INR | -3.55% |
| 2022 | 6.33 Billion INR | 19.42% |
| 2021 | 5.3 Billion INR | 9.67% |
| 2020 | 4.83 Billion INR | 34.1% |
| 2019 | 3.6 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.22 Billion INR | -32.77% |
| 2023 FY | 6.11 Billion INR | -3.55% |
| 2023 Q3 | 1.93 Billion INR | -7.53% |
| 2023 Q2 | 2.09 Billion INR | 85.16% |
| 2023 Q4 | 1.82 Billion INR | -5.81% |
| 2023 Q1 | 1.13 Billion INR | -35.92% |
| 2022 Q2 | 1.23 Billion INR | -12.6% |
| 2022 FY | 6.33 Billion INR | 19.42% |
| 2022 Q4 | 1.76 Billion INR | -7.68% |
| 2022 Q3 | 1.91 Billion INR | 54.29% |
| 2022 Q1 | 1.41 Billion INR | 0.0% |
| 2021 FY | 5.3 Billion INR | 9.67% |
| 2020 FY | 4.83 Billion INR | 34.1% |
| 2019 FY | 3.6 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.46 Million INR | -58317.255% |
| Biocon Limited | 91.73 Billion INR | 93.338% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | -93.435% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | -24.618% |
| FERMENTA BIOTECH LIMITED | 1.82 Billion INR | -235.374% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -370097.123% |
| Lyka Labs Limited | 145.95 Million INR | -4087.013% |
| Panacea Biotec Limited | 1.35 Billion INR | -350.902% |
| SAMSRITA LABS LIMITED | -1.28 Million INR | 476381.808% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 329.57 Million INR | -1754.209% |
| Supriya Lifescience Limited | 2.65 Billion INR | -130.448% |
| Syngene International Limited | 12.43 Billion INR | 50.868% |
| TAKE Solutions Limited | 183.42 Million INR | -3231.714% |
| Titan Biotech Limited | 884.66 Million INR | -590.777% |
| Transgene Biotek Limited | -1.69 Million INR | 361271.927% |
| Vanta Bioscience Limited | 7.12 Million INR | -85729.059% |